Solid-organ malignancy in patients with hidradenitis suppurativa treated with tumour necrosis factor-alpha inhibitors: a case series

被引：0
|
作者：
Lynch, Fiona [1 ]
Walsh, Mary-Catherine [1 ]
Sadlier, Muriel [1 ]
机构：
[1] Univ Hosp Limerick, Dept Dermatol, Limerick, Ireland
来源：
CLINICAL AND EXPERIMENTAL DERMATOLOGY | 2023年 / 48卷 / 05期
关键词：
D O I：
10.1093/ced/llad030
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
[No abstract available]
引用
收藏
页码：553 / 554
页数：2
相关论文
共 50 条
  • [21] THE IMPACT OF NON-PERSISTENCE ON THE DIRECT AND INDIRECT COSTS IN PATIENTS TREATED WITH SUBCUTANEOUS TUMOUR NECROSIS FACTOR-ALPHA INHIBITORS IN GERMANY
    Ziegelbauer, K.
    Huebinger, M.
    Dombrowski, S.
    Kostev, K.
    Friedrichs, M.
    Friedel, H.
    Kachroo, S.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1834 - 1834
  • [22] The impact of non-persistence on the direct and indirect costs in patients treated with subcutaneous tumour necrosis factor-alpha inhibitors in Germany
    Ziegelbauer, Kathrin
    Kostev, Karel
    Huebinger, Maximilian
    Dombrowski, Silvia
    Friedrichs, Michael
    Friedel, Heiko
    Kachroo, Sumesh
    [J]. RHEUMATOLOGY, 2018, 57 (07) : 1276 - 1281
  • [23] Development of low blood glucose readings in nine non-diabetic patients treated with tumor necrosis factor-alpha inhibitors: a case series
    Jadwiga B Czajkowska
    Brandon Shutty
    Susan Zito
    [J]. Journal of Medical Case Reports, 6 (1)
  • [24] Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients
    Chabbert, C.
    Adamski, H.
    Guillet, G.
    Sassolas, B.
    Misery, L.
    Perrinaud, A.
    Machet, L.
    Quereux, G.
    Esteve, E.
    Solau-Gervais, E.
    Saraux, A.
    Polard, E.
    Lesimple, T.
    Le Gall, F.
    Dreno, B.
    Dupuy, A.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2014, 28 (11) : 1540 - 1544
  • [25] Possible Paradoxical Photosensitive Psoriasis Induced by Tumour Necrosis Factor-alpha Inhibitors
    Bataille, Pauline
    De Masson, Adele
    Vignon-Pennamen, Marie-Dominique
    Bouaziz, Jean-David
    Gornet, Jean-Marc
    [J]. ACTA DERMATO-VENEREOLOGICA, 2019, 99 (13) : 1293 - 1294
  • [26] Increased Serum Tumour Necrosis Factor-α in Hidradenitis Suppurativa Patients: Is There a Basis for Treatment with Anti-Tumour Necrosis Factor-α Agents?
    Matusiak, Lukasz
    Bieniek, Andrzej
    Szepietowski, Jacek C.
    [J]. ACTA DERMATO-VENEREOLOGICA, 2009, 89 (06) : 601 - 603
  • [27] Tumour necrosis factor-alpha inhibitors in spondyloarthropathies and infections; Experience with 136 patients from a single center
    Ramonda, R.
    Modesti, V.
    Lo Nigro, A.
    Campana, C.
    Frallonardo, P.
    Contessa, C.
    Botsios, C.
    Punzi, L.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2008, 26 (01) : S87 - S87
  • [28] Successful treatment of recalcitrant hidradenitis suppurativa with risankizumab after failure of anti-tumour necrosis factor alpha
    Marques, E.
    Arenberger, P.
    Smetanova, A.
    Gkalpakiotis, S.
    Zimova, D.
    Arenbergerova, M.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (05) : 966 - 967
  • [29] Hidradenitis suppurativa management using tumor necrosis factor inhibitors in patients younger than 18 years: A series of 12 cases
    Fougerousse, Anne-Claire
    Reguiai, Ziad
    Roussel, Aude
    Becherel, Pierre-Andre
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (01) : 199 - 201
  • [30] MRSA infections in patients treated with tumour necrosis factor inhibitors
    Akhmed, N.
    Lichtenstein, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (11) : 1788 - 1789
12345